Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CN Creative Ltd.

www.cncbio.com

Latest From CN Creative Ltd.

U.K. Packages All Electronic Cigarettes Under Medical Regulation

The U.K. pharma regulator requires all electronic cigarettes to be licensed as nonprescription medicines beginning in 2016, noting concerns about product quality. Meanwhile, FDA considers allowing e-cigarettes to be marketed as nicotine replacement therapy on a case-by-case basis.

Consumer Medical Device

Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions

Stakeholders discussed electronic cigarettes at an FDA public hearing on smoking cessation, reflecting big tobacco’s buy-in to the market. Firms appear to have a choice between remaining in tobacco’s regulatory space, or following the costly, potentially unclear route to an NDA.

Consumer United States

Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions

Stakeholders discussed electronic cigarettes at an FDA public hearing on smoking cessation, reflecting big tobacco’s buy-in to the market. Firms appear to have a choice between remaining in tobacco’s regulatory space, or following the costly, potentially unclear route to an NDA.

Consumer United Kingdom

FDA Delves Into Broader Smoking Cessation Approach

FDA’s notice for a public hearing on smoking cessation approaches suggest a willingness to take an expanded approach to nicotine replacement therapy approvals and indications. Discussion topics include fast-track and accelerated approval authorities for NRTs and extended use of the products.

Consumer United States
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • CN Creative Ltd.
  • Senior Management
  • Tim Byrne, CFO
    Dale R Pfost, PhD, Chmn.
    Anthony Sefton, Sales Mgr.
  • Contact Info
  • CN Creative Ltd.
    Phone: 845 54 1651
    48 Grafton St.
    Manchester, M13 9XX
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register